Anitua, E.; Zalduendo, M.; Troya, M.; Alkhraisat, M.H.; Blanco-Antona, L.A.
Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization. Int. J. Mol. Sci. 2022, 23, 6552.
https://doi.org/10.3390/ijms23126552
AMA Style
Anitua E, Zalduendo M, Troya M, Alkhraisat MH, Blanco-Antona LA.
Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization. International Journal of Molecular Sciences. 2022; 23(12):6552.
https://doi.org/10.3390/ijms23126552
Chicago/Turabian Style
Anitua, Eduardo, Mar Zalduendo, Maria Troya, Mohammad H. Alkhraisat, and Leticia Alejandra Blanco-Antona.
2022. "Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization" International Journal of Molecular Sciences 23, no. 12: 6552.
https://doi.org/10.3390/ijms23126552
APA Style
Anitua, E., Zalduendo, M., Troya, M., Alkhraisat, M. H., & Blanco-Antona, L. A.
(2022). Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization. International Journal of Molecular Sciences, 23(12), 6552.
https://doi.org/10.3390/ijms23126552